Navigation Links
Medarex Announces 2007 Fourth Quarter and Year End Financial Results
Date:2/26/2008

), and (iii) approximately $2.7 million of increased costs associated with the development of ipilimumab (MDX-010). General and administrative expenses decreased by $5.0 million for the year ended December 31, 2007, from $51.9 million in 2006 to $46.9 million in 2007. The 2007 decrease is primarily attributable to lower legal and other professional fees.

Medarex ended 2007 with approximately $348.8 million in cash, cash equivalents and marketable securities. Approximately $4.9 million of this balance relates to Celldex. In addition, the fair market value of Medarex's equity interest in Genmab was approximately $291.2 million as of December 31, 2007.

For the three-month period ended December 31, 2007, Medarex reported a net loss of $44.8 million, or ($0.35) per share. This compares to a net loss of $57.7 million, or ($0.46) per share for the three-month period ended December 31, 2006. Included in the consolidated net loss for the three-month period ended December 31, 2007 is a net loss of $3.7 million, or ($0.03) per share representing Medarex's share of the net loss of Celldex for the period and a non-cash charge of $4.8 million, or ($0.04) per share for stock based compensation expense recorded in accordance with FAS 123(R). Excluding the impact of these items, Medarex's net loss on a non-GAAP basis for the three- month period ended December 31, 2007 was $36.3 million, or ($0.29) per share.

Non-GAAP Financial Measurements

This press release and the accompanying tables include non-GAAP financial measures. Please see the section of the accompanying tables titled "Reconciliation of GAAP Net Loss to Non-GAAP Net Loss" for a description of these non-GAAP financial measures, including reasons for Medarex management's decision to use each measure, and reconciliations of these non-GAAP financial measures to the most directly comparable financial measures prepared in accordance with Generally Accepted Accounting Principles.

Medarex's produ
'/>"/>

SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Medarex to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
2. Medarex to Receive Milestone Payment for Submission of Regulatory Applications Requesting Approval of Ustekinumab (CNTO 1275) for Treatment of Psoriasis
3. PharmAthene and Medarex Announce Additional $0.8 Million U.S. Government Appropriation for Continued Development of Anthrax Therapeutic Valortim(TM)
4. Medarex to Present at the JPMorgan Small/Mid Cap Conference
5. Ono and Medarex Announce Allowance of Investigational New Drug Application for Fully Human Anti-PD1 Antibody
6. Grupo Casa Saba Announces Fourth Quarter 2007 Results
7. Lixte Biotechnology Holdings, Inc. Announces Further Developments Regarding the Anti-Cancer Activity of Its Patent-Pending Proprietary Compounds
8. Reproductive Medicine Associates of Texas Announces Open House in San Antonio
9. WallSt.net (www.WallSt.net) Announces Upcoming Interview With Chairman and CEO of flexSCAN, Inc.
10. Hospira Announces New Contract With HealthTrust Purchasing Group for Infusion Devices, Solutions and Equipment
11. Thomson Healthcare Announces Enhancements to Order Sets Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... The “Proteomics Market by Technology (Protein ... Plasmon Resonance, X-ray Crystallography) - Instruments, Reagents & ... studies the major market drivers, restraints, and opportunities ... of the World (RoW) , Browse 138 market ... and in-depth TOC on “Proteomics Market by Technology ...
(Date:8/21/2014)... Top10BestSEOHosting.com has recently compared many professional web ... ) is one of the best cheap web ... of Top10BestSEOHosting.com states, “It is hard to find ... have outperformed their competitors on hosting features, uptime, ... the best web hosting at affordable prices.” ...
(Date:8/21/2014)... 2014 An increasing amount of complaints ... their federal tax payment is being returned by their ... from the IRS, “tax@irs.gov”, it’s actually a phishing tactic ... financial information. , While similar scams have been going ... phishing activity is occurring right now. , First, ...
(Date:8/21/2014)... laryngeal cancer appear to have better survival if ... , Author: Uchechukwu C. Megwalu, M.D., M.P.H., of ... New York, and colleagues. , Background: Approximately 11,000 ... each year and squamous cell carcinoma accounts for ... 1991, total surgical removal of the larynx with ...
(Date:8/21/2014)... a low or very low birth weight may be ... The findings, which appear in Diabetes Care , ... 2 diabetes in African American populations, which has a ... Boston University,s Slone Epidemiology Center followed more than 21,000 ... the course of 16 years, analyzing characteristics such as ...
Breaking Medicine News(10 mins):Health News:Proteomics Market worth $20,696.4 Million by 2018 - New Research Report by MarketsandMarkets 2Health News:Proteomics Market worth $20,696.4 Million by 2018 - New Research Report by MarketsandMarkets 3Health News:Proteomics Market worth $20,696.4 Million by 2018 - New Research Report by MarketsandMarkets 4Health News:Proteomics Market worth $20,696.4 Million by 2018 - New Research Report by MarketsandMarkets 5Health News:iPage Reviews Unveiled Online At Top10BestSEOHosting.com 2Health News:Beware Of Phony “Tax Payment Rejected” IRS Emails 2Health News:Surgery associated with better survival for patients with advanced laryngeal cancer 2Health News:Low birth weight linked to higher incidence of type 2 diabetes in African American women 2
... suggests they,re less likely to separate reality from fiction ... adult-themed movies and television shows as children become sexually active ... Boston study finds. , It included 754 participants who were ... were aged 12 to 18. The earlier in their life ...
... to End Prostate Cancer to Take Strides for the CauseWASHINGTON, May ... runners are hitting the pavement to ramp up their running regimes ... Prostate Cancer has joined forces with the ING New York City ... formed a team to run in the race on Nov. 1. ...
... FY 2010 Proposed Medicare Cut Weakens Key Health Care ... Mo., May 4 The Coalition to Protect Senior ... a Medicare regulation put forward for implementation Friday by ... proposed Medicare rule, a Coalition spokeswoman said, would cut ...
... Show Increase In Searches, Social Media "Chatter," As Consumers Seek ... Add nose washing to the steps that ... hand washing and coughing in a tissue -- in an ... Google Insights For Search, "neti pot" increased as a search ...
... Physicians to Make the Most Informed Decisions When Time ... Medical Technologies continues to add to its portfolio of ... the tools necessary to make critical decisions regarding a ... recent participation in the Integrating the Healthcare Enterprise (IHE) ...
... The Illinois Soybean Association (ISA ) is ... (GCNF) in Cape Town , South ... of people from around the world will be participating in the ... CW Gaffner and Pat Dumoulin - will represent Illinois farmers and ...
Cached Medicine News:Health News:Viewing Adult-Themed TV Tied to Earlier Sex for Teens 2Health News:Team ZERO to Run to End Prostate Cancer in 2009 ING New York City Marathon 2Health News:Nation's Front Line Caregivers Mobilizing to Help Defeat Obama Implementation of Damaging Medicare Regulation 2Health News:Along With Hand Washing and Covering Up When Coughing, Add Nose Washing to Steps Consumers Looking to Take for Flu Prevention 2Health News:Greenway Medical Technologies' PrimeSuite Solution Provides OB/GYN Physicians With Instant Access to Labor and Delivery Information at Point-of-Care 2Health News:Greenway Medical Technologies' PrimeSuite Solution Provides OB/GYN Physicians With Instant Access to Labor and Delivery Information at Point-of-Care 3Health News:Greenway Medical Technologies' PrimeSuite Solution Provides OB/GYN Physicians With Instant Access to Labor and Delivery Information at Point-of-Care 4Health News:Illinois Soybean Association to Participate in Global Child Nutrition Forum in South Africa 2
(Date:8/21/2014)... , Aug. 21, 2014 InfinityQS International, ... Manufacturing Intelligence , today announces Infusion Chicago, ... event will be held Oct. 9-10, 2014, at ... designed to showcase the necessity for implementing a ... and Manufacturing Intelligence to gain insight into production ...
(Date:8/21/2014)... ROCHESTER, N.Y. , Aug. 21, 2014  The ... VSCP ), a leading provider of clinical trial imaging ... has been named chief financial officer, effective immediately.  Mr. ... officer since August 2013.  He joined VirtualScopics in January ... controller in February 2013. "When the board ...
(Date:8/21/2014)...  Cyberonics, Inc. (NASDAQ: CYBX ) today announced ... Quarterly highlights 1   Operating results for ... quarter of fiscal 2014, and other achievements, include: , ... 6.8%; , Strong international net sales of $13.2 million, ... , U.S. net product sales reached a new high of ...
Breaking Medicine Technology:InfinityQS to Host Manufacturing Intelligence Conference in Chicago 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 3VirtualScopics, Inc. Names James Groff Chief Financial Officer 4Cyberonics Reports Fiscal 2015 First Quarter Results 2Cyberonics Reports Fiscal 2015 First Quarter Results 3Cyberonics Reports Fiscal 2015 First Quarter Results 4Cyberonics Reports Fiscal 2015 First Quarter Results 5Cyberonics Reports Fiscal 2015 First Quarter Results 6Cyberonics Reports Fiscal 2015 First Quarter Results 7Cyberonics Reports Fiscal 2015 First Quarter Results 8Cyberonics Reports Fiscal 2015 First Quarter Results 9Cyberonics Reports Fiscal 2015 First Quarter Results 10Cyberonics Reports Fiscal 2015 First Quarter Results 11Cyberonics Reports Fiscal 2015 First Quarter Results 12Cyberonics Reports Fiscal 2015 First Quarter Results 13Cyberonics Reports Fiscal 2015 First Quarter Results 14Cyberonics Reports Fiscal 2015 First Quarter Results 15Cyberonics Reports Fiscal 2015 First Quarter Results 16
... controlled, Blanketrol II total body ... effective patient warming and/or cooling ... Blanketrol II offers the largest ... of any hyper-hypothermia system providing ...
... Zeiss is expanding the borders of ... excellent color reproduction, high-contrast images and ... optics provide improved resolution and contrast. ... Control Panel) combines all essential functions ...
Inquire...
Compact tray features all components for urethral catheterization....
Medicine Products: